Originally published In Press as doi:10.1074/jbc.M110688200 on February 4, 2002
J. Biol. Chem., Vol. 277, Issue 19, 17300-17307, May 10, 2002
Molecular Cloning and Characterization of Sphingolipid Ceramide
N-Deacylase from a Marine Bacterium, Shewanella
alga G8*
Masako
Furusato
,
Noriyuki
Sueyoshi
,
Susumu
Mitsutake
,
Keishi
Sakaguchi
,
Katsuhiro
Kita
,
Nozomu
Okino
,
Sachiyo
Ichinose§,
Akira
Omori§, and
Makoto
Ito
¶
From the
Department of Bioscience and Biotechnology,
Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu
University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581 and the
§ Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida 194-8511, Tokyo, Japan
Received for publication, November 7, 2001, and in revised form, January 15, 2002
 |
ABSTRACT |
Recently, lyso-sphingolipids have been identified
as ligands for several orphan G protein-coupled receptors, although the molecular mechanism for their generation has yet to be clarified. Here,
we report the molecular cloning of the enzyme, which catalyzes the
generation of lyso-sphingolipids from various sphingolipids (sphingolipid ceramide N-deacylase). The 75-kDa enzyme was
purified from the marine bacterium, Shewanella alga G8, and
its gene was cloned from a G8 genomic library using sequences of the
purified enzyme. The cloned enzyme was composed of 992 amino acids,
including a signal sequence of 35 residues, and its molecular
weight was estimated to be 109,843. Significant sequence
similarities were found with an unknown protein of Streptomyces
fradiae Y59 and a Lumbricus terrestris lectin but not
other known functional proteins. The 106-kDa recombinant enzyme
expressed in Escherichia coli hydrolyzed various
glycosphingolipids and sphingomyelin, although it seems to be much less
active than the native 75-kDa enzyme. In vitro translation
using wheat germ extract revealed the activity of a 75-kDa deletion
mutant lacking a C terminus to be much stronger than that of the
full-length enzyme, suggesting that C-terminal processing is necessary
for full activity.
 |
INTRODUCTION |
Glycosphingolipids
(GSLs)1 and sphingomyelin
(SM) are ubiquitous components of the plasma membranes of vertebrates.
Recently, they were found to be accumulated in cell-surface
microdomains together with cholesterol and
glycosylphosphatidylinositol-anchored proteins (1, 2). Lyso-GSLs
and lyso-SM, the N-deacylated derivatives of GSLs and
SM, respectively, are detected in normal tissues at very low levels (3)
but accumulated in several types of inherited sphingolipid storage
diseases (4-6). Several lines of evidence suggest a biological role
for lyso-GSLs in cell activities. For example, lyso-GM3 strongly
inhibited the tyrosine-specific autophosphorylation of the epidermal
growth factor receptor of A431 cells, in which lyso-GM3 was actually
detected with GM3 (7). Various lyso-sphingolipids inhibit protein
kinase C, and this may be responsible for the pathogenesis of
sphingolipidoses (8). Psychosine (galactosylsphingosine) inhibited
cytokinesis to induce the formation of multinuclear cells that are
observed in the brains of patients with globoid cell leukodystrophy
(9). Lyso-SM (sphingosylphosphorylcholine, SPC), was found to
accumulate in the brains of patients with Niemann-Pick disease type A
(10) or in the skin of patients with atopic dermatitis (11) and is
considered to be related to their symptoms. SPC as well as lyso-GM1a
were found to induce apoptosis in neuronal cells (12).
Recently, the G protein-coupled receptors for lyso-sphingolipids have
been cloned and characterized; ovarian cancer G protein-coupled receptor (OGR1) (13) and T cell death-associated gene 8 (TDAG8) (14) were identified as a receptor for SPC and psychosine,
respectively, and GPR4, with high sequence similarity to OGR1, was a
receptor with high affinity for SPC and low affinity for
lyso-phosphatidylcholine (15).
Although the molecular mechanism underlying the generation of
lyso-sphingolipids in mammals remains unclear, lyso-GSL-generating enzymes have been found in several microorganisms, including
Nocardia sp. (16), Pseudomonas sp. (17), and
Streptomyces sp. (18). The enzyme from
Pseudomonas sp. TK4 was found to hydrolyze not only GSLs but
also SM, generating corresponding lyso-sphingolipids and fatty acids
(17). The TK4 enzyme is clearly distinguishable from ceramidase in that
it hydrolyzes the same linkage of free ceramide but not GSLs or SM (19,
20) and thus has been tentatively designated sphingolipid ceramide
N-deacylase (SCDase) (17).
Herein we report the molecular cloning and characterization of a novel
SCDase from a newly isolated strain of Shewanella alga G8.
Although both the TK4 and G8 enzymes efficiently hydrolyzed various
GSLs and SM, a distinct difference in specificity was found in the
hydrolysis of NBD-GalCer, in which the
-position of the fatty acid
was labeled with NBD, and
2-palmitoyl-5-nitrophenyl-
-D-glucoside (2P5N-Glc). That
is, NBD-GalCer was efficiently hydrolyzed by G8 SCDase but not TK4
SCDase, whereas 2P5N-Glc was hydrolyzed by the TK4 enzyme but
completely resistant to the G8 enzyme. This study also suggests that
the processing of the C-terminal region of the G8 enzyme is necessary
for the full expression of activity.
This is the first report of the gene cloning of SCDase, information
that should prove indispensable for the elucidation of the structure
and functions of the enzyme and facilitate developments in
lyso-sphingolipid-related biology and pathophysiology.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Crude ganglioside mixture was prepared from
bovine brain as described previously (21), and GM1a was prepared from
the crude ganglioside mixture using sialidase-producing bacteria,
Pseudomonas sp. YF-2, as a microbial catalyst by the method
described in a previous study (22). GD1b, GM3, asialoGM1,
lactosylceramide (LacCer), galactosylceramide (GalCer),
glucosylceramide (GlcCer), restriction endonucleases, and Ligation Pack
were purchased from Wako Pure Chemical Industries (Osaka, Japan). Other
GSLs were obtained from Iatron Laboratories, Inc. (Tokyo, Japan). SM
and ceramide from bovine brain were purchased from Matreya.
D-erythro-(2S,3R)-SPC was
purchased from Biomol Co. [14C]SM (labeled at the choline
residue) was obtained from ARC. Triton X-100 and Lubrol PX were
obtained from Sigma Chemical Co. and Nacalai Tesque Inc. (Kyoto,
Japan), respectively. A precoated Silica gel 60 TLC plate was obtained
from Merck (Darmstadt, Germany). pET23b and modifying enzymes were
purchased from Takara Shuzo Co. (Kyoto, Japan) and
[
-32P]dCTP was from Amersham Biosciences, Inc.
(Buckinghamshire, England). All other reagents were of the highest
purity available.
Isolation and Identification of Strain G8--
The
SCDase-producing bacterium G8 was isolated from sea sand using medium A
(0.05% NH4Cl, 0.05% K2HPO4, 0.1%
yeast extract, 2.0% NaCl, and 0.01% bovine brain gangliosides, pH
7.0), and identified according to the 8th edition of Bergey's Manual
of Determinative Bacteriology (23). This strain is currently maintained
in a medium containing crude gangliosides (0.5% polypeptone, 0.1%
yeast extract, 2% NaCl, 0.1% bovine brain gangliosides, and 1.6%
agar, pH 7.0) in our laboratory.
Phylogenetic Analysis--
16 S rDNA was amplified using the
universal primers p27f (5'-AGA GTT TGA TCM TGG CTC AG-3'; positions
8-27; Escherichia coli numbering (24)) and p1492r (5'-GGC
TAC CTT GTT ACG ACT T-3'). PCR products were purified from 1.0%
agarose gel and sequenced directly using nine different sequencing
primers (25). The nucleotide sequences were aligned and analyzed using
Clustal W (26), with other 16 S rDNA sequences obtained from the
Ribosomal Data base Project II (27).
Enzyme Assay--
The activity of SCDase was measured using GM1a
as the substrate as described previously (17). In a standard assay, the
reaction mixture contained 10 nmol of GM1a and an appropriate amount of the enzyme in 20 µl of 25 mM sodium acetate buffer, pH
6.0, containing 0.1% Triton X-100. Following incubation at 37 °C
for 30 min, the reaction was stopped by heating in a boiling water bath
for 5 min. The reaction products were freeze-dried in a Speed Vac
concentrator, dissolved in 15 µl of chloroform/methanol (1:2, v/v),
and analyzed by TLC using solvent I (chloroform/methanol/0.02%
CaCl2, 5/4/1, v/v) as the developing solvent. GSLs and
lyso-GSLs were visualized by spraying the plates with
orcinol-H2SO4 reagent and scanning them with a
Shimadzu CS-9300 chromatoscanner with the reflectance mode set at 540 nm. The extent of hydrolysis was calculated as follows: hydrolysis
(%) = (peak area for lyso-GM1a generated) × 100/(peak area
for remaining GM1a + peak area for lyso-GM1a generated). One enzyme
unit was defined as the amount capable of catalyzing the release of 1 µmol of lyso-GM1a/min from GM1a under the conditions indicated above.
A value of 10
3 and 10
6 units of enzyme was
expressed as 1 milliunit (mU) and 1 microunit (µU), respectively. The
activity of SCDase was also measured using C12-NBD-GalCer,
[14C]SM (labeled at the choline residue) or
[14C]GM1a (labeled at the stearic acid) as a substrate as
described below. C12-NBD-GalCer was prepared by the method described by Nakagawa et al. (28). The reaction mixture contained 100 pmol of C12-NBD-GalCer and an appropriate amount of the enzyme in
20 µl of 25 mM sodium acetate buffer, pH 6.0, containing 0.1% Triton X-100. Following incubation at 37 °C for 30 min, the reaction was terminated by heating in a boiling water bath for
5 min. The sample was evaporated, dissolved in 15 µl of
chloroform/methanol (2/1, v/v), and applied to a TLC plate, which was
developed with solvent I. NBD-dodecanoic acid released by the action of
the enzyme and the remaining C12-NBD-GalCer were separated on a TLC and
then analyzed and quantified with a Shimadzu CS-9300 chromatoscanner (excitation 475 nm, emission 525 nm). The hydrolysis of
[14]SM or [14]GM1a was performed as
follows; the reaction mixture contained 100 pmol of
14C-substrate, 900 pmol of each cold substrate, and 60 µU
of SCDase in 20 µl of 25 mM sodium acetate buffer, pH
6.0, containing 0.1% Triton X-100. After incubation at 37 °C for
the periods indicated, the sample was evaporated, dissolved in 20 µl
of chloroform/methanol (2/1, v/v), and applied to a TLC plate, which
was developed with solvent I. An imaging analyzer (BAS1500, Fuji Film,
Japan) was used for analysis and quantification of the
14C-substrate and 14C-product.
2-Palmitoyl-5-nitrophenyl-
-D-glucoside (2P5N-Glc) was
used as an alternative substrate for SCDase. 2P5N-Glc was prepared
according to the method described in a previous study (29). The
reaction mixture contained 50 µg of 2P5N-Glc and an appropriate
amount of the enzyme in 200 µl of 25 mM sodium acetate buffer, pH 6.0, containing 0.8% Triton X-100. Following incubation at
37 °C for 30 min, the optical density at 405 nm was measured to
estimate the release of
2-amino-5-nitrophenyl-
-D-glucoside from 2P5N-Glc. For
quantification of hydrolysis of 2P5N-Glc, 10 µl of reaction mixture
was dried and re-dissolved in 20 µl of chloroform/methanol (2/1, v/v)
and applied to a TLC plate, which was developed with solvent I. The
released 2-amino-5-nitrophenyl-
-D-glucoside was
determined by the orcinol-H2SO4 method. Reverse
hydrolysis was measured by the method described previously (30). The
mixture contained 100 pmol of [14C]stearic acid, 900 pmol
of stearic acid, 2 nmol of D-erythro-SPC (Biomol
Co.), and 60 µU of SCDase in 20 µl of 25 mM sodium
acetate buffer, pH 6.0, containing 0.1% (w/v) Triton X-100. Following incubation at 37 °C for the periods indicated, the reaction was terminated by heating in a boiling water bath for 5 min. The sample was
evaporated, dissolved in 20 µl of chloroform/methanol (2/1, v/v), and
applied to a TLC plate, which was developed with solvent I. An imaging
analyzer (BAS1500, Fuji Film, Japan) was used for analysis and
quantification of the [14C]SM generated and
[14C]stearic acid unreacted. Exoglycosidases were assayed
using p-nitrophenylglycosides (31) as a substrate.
Purification of SCDase--
Inocula from an agar slant of G8
were introduced into a cotton-plugged 500-ml flask containing 100 ml of
sterilized peptone-yeast extract-ganglioside (PYG) medium (0.5%
polypeptone, 0.1% yeast extract, 2.0% NaCl, 0.1% bovine brain
gangliosides, pH 7.0) and incubated at 25 °C for 22 h with
vigorous shaking. The culture fluid was centrifuged at 8300 rpm for 30 min, and the supernatant (4,600 ml) was then concentrated using an
Ultrafiltration System (Millipore) with a 30,000 cut membrane. The
concentrated fluid was applied to a Butyl-Toyopearl 650M column (80 ml;
Tosoh Co., Japan), previously equilibrated with 20 mM
Tris-HCl, pH 7.5 (buffer A), containing 2.0 M NaCl. The
enzyme was eluted from the column with an increasing Lubrol PX from 0 to 2.0% in buffer A, using a BPLC-600FC HPLC system (Yamazen Co.,
Japan) at a flow rate of 5 ml/min. The active fractions were pooled
(130 ml) and then applied to a DEAE-Sepharose FF column (30 ml,
Amersham Biosciences, Inc.), previously equilibrated with buffer A
containing 0.1% Lubrol PX, using a BPLC-600FC HPLC system (Yamazen
Co., Japan). The enzyme was eluted from the column with increasing
concentrations of NaCl up to 1 M at a flow rate of 5 ml/min. The active fractions were pooled (129 ml), and half of this
sample was applied to a HiTrap Blue column (1.0 ml, Amersham
Biosciences, Inc.) equilibrated with buffer A, containing 1.0 M NaCl. The enzyme was eluted from the column with
decreasing concentrations of NaCl down to 0 M at a flow
rate of 1 ml/min.
Protein Assay and SDS-PAGE--
The amount of protein was
measured by the bicinchoninic acid protein assay (Pierce) with bovine
serum albumin as the standard. SDS-PAGE was carried out according to
the method of Laemmli (32). The proteins on SDS-PAGE gel were
visualized with a silver-staining solution (33) and quantified by a
Shimadzu CS-9300 chromatoscanner with the reflection mode set at 540 nm.
Amino Acid Microsequencing--
The purified SCDase was
concentrated with a Y-shaped gel (160 × 160 × 2 mm)
modified from a funnel-shaped one (34). After concentration, the
protein band (75 kDa) localized with Coomassie Brilliant Blue was cut
out, reduced with dithiothreitol, and loaded again on the well of a
SDS-PAGE gel. After electrophoresis, the gel was blotted onto a
polyvinylidene difluoride membrane (Immobilon-P, Millipore) and stained
with Coomassie Brilliant Blue. The SCDase band was cut out and treated
in situ with lysylendopeptidase AP-1 (Wako Pure Chemical
Industries, Japan). Peptides released from the membrane were
fractionated by reversed-phase HPLC using a C8 column (RP-300, 1.0 × 100 mm, Applied Biosystems) and sequenced with a pulse-liquid phase
protein sequencer (Procise 492 cLc, Applied Biosystems).
Molecular Cloning and DNA Sequencing--
General cloning
techniques were used, essentially as described by Sambrook et
al. (35). Genomic DNA of S. alga G8 was isolated by the
method of Saito and Miura (36). Nucleotide sequences were determined by
the dideoxynucleotide chain termination method with a BigDye Terminator
Cycle Sequencing Ready Reaction Kit (Applied Biosystems) and a DNA
sequencer (model 377A, Applied Biosystems).
PCR Amplification--
PCR with degenerate oligonucleotides was
used to amplify a DNA fragment encoding the SCDase. Sense and antisense
oligonucleotide primers were designed using the N-terminal amino acid
sequence of C-603 and the internal amino acid sequence of C-606. PCR
was performed with the G8 genomic DNA as a template in a GeneAmp PCR System 2400 (Applied Biosystems) for 35 cycles (each consisting of
denaturation at 95 °C for 20 s, annealing at 52 °C for
30 s, and extension at 72 °C for 1.5 min) using AmpliTaq Gold
(Applied Biosystems). Amplified PCR products were cloned into the
pGEM-T Easy vector (Promega), and their DNA was sequenced. One PCR
product (named probe 1) contained the deduced amino acid sequence found in the purified SCDase.
Isolation of a Genomic DNA Clone Encoding SCDase--
Genomic
DNA (3 µg) was digested with various restriction endonucleases, and
the digests were fractionated by 0.7% agarose gel electrophoresis by
the standard method (35). DNA was transferred from agarose gels onto
nylon membranes (Hybond N+, Amersham Biosciences) according to the
protocol of the manufacturer. Probe 1 was labeled with
[
-32P]dCTP using a Ready-To-Go DNA labeling kit
(Amersham Biosciences) and used for hybridization, which was performed
in 0.5 M sodium phosphate buffer, pH 7.0, containing 1 mM EDTA and 7% SDS at 65 °C for 16 h. After
hybridization, the membrane was washed three times with 40 mM sodium phosphate buffer, pH 7.0, containing 1% SDS at
65 °C and exposed on an imaging plate, which was then analyzed with
a BAS1500 imaging analyzer (Fuji Film, Japan). Judging from the
Southern blot of the EcoRV digest obtained using probe 1, the 4.5-kbp fragment contained the SCDase gene. To clone the gene, an
EcoRV digest was prepared using 10 µg of G8 genomic DNA.
Restriction fragments of the DNA were fractionated by preparative
1.0-% agarose gel electrophoresis, and 4.5-kbp fragments were
extracted from the gel. The EcoRV fragments were ligated to
the EcoRV site of pBluescript II SK (Stratagene). The
recombinant plasmids thus obtained were used to transform
Escherichia coli DH5
, which were employed for the
preparation of a DNA library enriched with the SCDase gene. Colony
hybridization was performed by the standard procedure using probe 1. One clone was selected, and the plasmid in the clone was designated pSCD1.
Construction of an Expression Plasmid with the SCDase
Gene--
The following primers were used for PCR; UN1 (5'-GAC
GCT AGC ATG AAA AAG CTA ATC GGA CAT-3'), and LC2 (5'-CTT
GAG GCT GGA CTT CCA CTT CTG-3'). UN1
contained a NheI site (underlined) and LC2 contained a
XhoI restriction site (double underlined). PCR was performed
in a GeneAmp PCR System 9600 (Applied Biosystems) for 30 cycles (each
consisting of denaturation at 98 °C for 10 s and extension at
68 °C for 3.5 min) using Pyrobest DNA polymerase and pSCD1 as a
template. After gel purification, the amplified products were digested
with NheI and XhoI. The
NheI/XhoI fragments were cloned into the
NheI/XhoI-digested pET23b. The recombinant plasmid was designated pETSCD-T.
In Vitro Translation of SCDase and Its Deletion
Mutant--
The following primers were used for PCR; UN1ERV (5'-GCT
GAT ATC ATG AAA AAG CTA ATC GGA CAT-3'), LSCD2125HisXho
(5'-AAA
TCA ATG ATG ATG ATG ATG ATG GTG GGC
TTC TGC GCG CTC CCA-3'), and LSCD2955HisXho (5'-AAA
TCA ATG ATG ATG ATG ATG ATG GAG GCT GGA CTT CCA CTT CTG).
UN1ERV contained an EcoRV restriction site (underlined), and
LSCD2125HisXho and LSCD2955HisXho contained an XhoI
restriction site (double underlined). PCRs were performed in a T
personal PCR System (Biometra, Germany) for 30 cycles (each consisting
of denaturation at 98 °C for 10 s and extension at 68 °C for
3 min) using Pyrobest DNA polymerase, pSCD1 as a template, and the
following sets of primers: UN1ERV-LSCD2955HisXho for the construction
of pEUSCD-T (encoding wild type SCDase) and UN1ERV-LSCD2125HisXho for
the construction of pEUSCD-del (encoding SCDase deletion mutant). After gel purification, the amplified products were digested with EcoRV and XhoI. The
EcoRV-XhoI fragments were cloned into the EcoRV/XhoIdigested pEU-NII vector. mRNA
encoding the wild type or deletion mutant of SCDase was prepared from
pEUSCD-T or pEUSCD-del using T7 RNA polymerase. In vitro
translation was performed using a PROTEIOS wheat germ cell-free
protein synthesis kit (TOYOBO, Japan) according to the manufacturer's protocol.
Expression of Recombinant SCDase--
Escherichia
coli BL21(DE3)pLysS cells transformed with pETSCD-T were grown
at 37 °C in Luria-Bertani medium containing 100 µg/ml ampicillin
until the optical density at 600 nm reached about 1.0. Then,
isopropyl-1-thio-
-D-galactopyranoside (IPTG) was added to the culture at a final concentration 1 mM, and
cultivation was continued for an additional 2 h at 37 °C. Cells
were harvested by centrifugation, suspended in extraction buffer (10 mM Tris-HCl buffer, pH 7.5, containing 0.5 mM
4-(2-aminoethyl)-benzensulfonyl fluoride hydrochloride and 1% Triton
X-100), and sonicated. After sonication, the solution was centrifuged
at 15,000 rpm for 3 min, and the supernatant obtained was used as the
crude enzyme solution.
Other Methods--
The nucleotide and amino acid sequences were
evaluated using the DNASIS computer program developed by Hitachi
Software Engineering (Japan).
 |
RESULTS |
Purification of SCDase--
The newly isolated SCDase-producing
bacterium G8 was assigned to S. alga based on its
morphological, physiological, and biochemical characteristics and on
the results of a phylogenetic analysis using 16 S rDNA. G8 released
SCDase into the culture medium (12 units/liter of culture) when
cultivated at 25 °C for 20-24 h in a PYG medium. SCDase was
then purified from 4.6 liters of the culture supernatant by
Ultrafiltration and sequential chromatography using Butyl-Toyopearl
650M and DEAE-Sepharose FF, as described under "Experimental
Procedures." SCDase was finally purified 1600-fold with an overall
yield of 24% (Table I).
Purity and Molecular Mass of SCDase--
The final preparation of
G8 SCDase was completely free from the following enzymes:
- and
-galactosidases,
- and
-glucosidases,
- and
-mannosidases,
-N-acetylhexosaminidase,
-N-acetylgalactosaminidase,
-N-acetylglucosaminidase, and
-L-fucosidase, as confirmed by activity determination
using 0.1 mU of the purified SCDase for each assay and an appropriate
substrate for 16 h. The purified enzyme gave one major protein
band having a molecular mass of 75 kDa on SDS-PAGE after staining with
a silver-staining solution under reducing conditions (Fig.
1A). To examine whether or not the 75-kDa band is SCDase per se, the SCDase preparation
after DEAE-Sepharose FF chromatography was further applied to a column of HiTrap Blue, and an aliquot of the eluent was subjected to an assay
for SCDase activity as well as SDS-PAGE. The elution profile of SCDase
activity on the HiTrap Blue column was found to exactly coincide with
that of the 75-kDa band on SDS-PAGE (Fig. 1B), indicating
that the 75-kDa protein is likely to be SCDase.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Identification of SCDase on SDS-PAGE.
A, SDS-PAGE of G8 SCDase under reducing conditions.
SCDase, SCDase from DEAE-Sepharose FF. STD,
standard proteins (molecular masses in parentheses) were: phosphorylase
b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic
anhydrase (30 kDa), soybean trypsin inhibitor (20 kDa), and lysozyme
(14 kDa). Proteins were stained with silver staining solution.
B, elution profiles of SCDase activity and 75-kDa protein
from HiTrap Blue chromatography. Aliquots of each fraction were
subjected to SCDase assay and SDS-PAGE. Proteins were stained with
silver staining solution, and the content of the 75-kDa protein was
determined using a Shimadzu CS-9300 chromatoscanner with the
reflectance mode set at 540 nm. SCDase activity was determined using
GM1a as a substrate by the method described under "Experimental
Procedures." , activity for SCDase; , elution of the 75-kDa
protein (A at 540 nm).
|
|
Molecular Cloning of the SCDase Gene--
Four peptides (C-599,
C-606, C-614, and C-616) were obtained from the purified 75-kDa SCDase
after digestion with lysylendopeptidase and subjected to amino acid
microsequencing. The N-terminal amino acid sequence was also determined
using the purified native enzyme (C-603). Finally, 59 amino acid
residues of the SCDase were determined. PCR was performed using one set
of primers (SS2a, 5'-CTNGCNCARCARTGYTT-3'; SA3,
5'-CCNSAYTGNACRTCDAT-3') and G8 genomic DNA as a template. A 997-bp PCR
product was obtained (probe 1), which contained DNA sequences encoding
the peptide sequences of C-603, C-599, and C-606 (Fig.
2A). Southern blotting using
-32P-labeled probe 1 showed a 4.5-kbp band in the G8
genomic DNA digested with EcoRV. A clone, designated as
pSCD1, containing a 4.5-kbp insert was isolated from a DNA library
enriched with the SCDase gene. The nucleotide sequence of pSCD1 was
determined, and a putative open reading frame was found. The amino acid
sequences of C-603, C-599, C-606, C-614, and C-616 were found in the
deduced amino acid sequence of the open reading frame (Fig.
2A). We sequenced 4434 nucleotides of the clone pSCD1, which
includes an open reading frame of position 319 through 3294.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 2.
DNA and deduced amino acid sequences
(A) and hydropathy plot (B) of the
SCDase. A, the deduced amino acid sequence is shown as
a one-letter code below the nucleotide sequence. Amino acids
determined by peptide sequencing are underlined (C-606,
C-603, C-599, C-614, and C-616). The amino acid residues are numbered
beginning with the first methionine. The termination codon is denoted
by an asterisk. A DNA sequence with bold under
line represents the probe 1 used for the colony hybridization.
B, hydropathy analysis of the coding region based upon the
deduced amino acids according to Kyte and Doolittle (48). Amino acid
residues are numbered beginning with the first
methionine.
|
|
DNA and Deduced Amino Acid Sequences of SCDase--
The open
reading frame, 2976 bp long with 992 codons, encoded a signal sequence
of 35 residues and a mature protein of 957 amino acid residues (Fig.
2A). The molecular weight of the SCDase was estimated to be
109,843 from the deduced amino acid sequences, which was quite
different from that of the SCDase (75 kDa) purified from S. alga G8. The predicted pI was 5.34. All of the peptide sequences
determined and a hydrophobic motif composed of 35 amino acid residues
starting with ATG were found in the deduced amino acid sequence (Fig.
2A). The presence of the hydrophobic motif was also clearly
indicated by hydrophobicity plot analysis (Fig. 2B). The
finding of a signal peptide sequence was consistent with the
observation that the SCDase was secreted into the culture medium.
Expression of Recombinant SCDase--
The expression plasmid,
pETSCD-T, was constructed by inserting a fragment of the coding
sequence with a putative signal sequence between the NheI
and XhoI sites of the plasmid pET23b. In pETSCD-T, transcription of the recombinant gene is controlled by the T7 promoter
and can be induced by IPTG. The 106-kDa protein was detected with the
anti-histidine tag (C-term) monoclonal antibody (Invitrogen) on
SDS-PAGE (Fig. 3A), which was
consistent with the molecular mass deduced from the SCDase gene. Cell
lysates from transfectants containing pETSCD-T hydrolyzed
[14C]SM (labeled at the choline residue) to produce
[14C]SPC whereas those of mock transfectants did not,
indicating that the recombinant protein possesses the SCDase activity
(Fig. 3B). The extent of hydrolysis of [14C]SM
by the recombinant SCDase was time-dependent and reached a
plateau after incubation for 120 min under the conditions used (Fig.
3C). The reaction of TK4 SCDase is a reversible one in which the amide linkage of ceramide is either cleaved or synthesized (30).
The recombinant G8 enzyme also catalyzed the reverse hydrolysis reaction (condensation), i.e., [14C]stearic
acid was condensed with SPC to generate [14C]SM (Fig.
3D). The synthesis of SM by the reverse hydrolysis reaction
increased during incubation and reached a plateau after 120 min (Fig.
3E). Cell lysates of mock transfectants showed no activity
for the reverse reaction (Fig. 3D).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Expression and activity of recombinant G8
SCDase. A, Western blotting of the recombinant G8
SCDase. E. coli BL21(DE3)pLysS cells transformed with
pETSCD-T were cultured at 37 °C for 2 h after addition of IPTG.
The cell lysate was analyzed by 7.5% SDS-PAGE and transferred onto
nitrocellulose membrane for detection with anti-His tag (C-term)
monoclonal antibody (Invitrogen). B, time course for
hydrolysis of [14C]SM by the recombinant G8 SCDase. The
reaction mixture contained 100 pmol of [14C]SM (labeled
at the choline residue), 900 pmol of unlabeled SM, and 60 µU of
SCDase (cell lysate of E. coli BL21(DE3)pLysS transformed
with pETSCD-T) in 20 µl of 25 mM sodium acetate buffer,
pH 6.0, containing 0.1% Triton X-100. Mock represents the
incubation of substrate with cell lysate of E. coli
BL21(DE3)pLysS transformed with pET23b vector without SCDase gene.
After incubation at 37 °C for the periods indicated,
[14C]SPC was separated from [14C]SM using
TLC and analyzed by BAS1500 as described under "Experimental
Procedures." C, quantification of B by BAS1500.
D, time course for the generation of [14C]SM
by the reverse hydrolysis reaction of the recombinant SCDase. The
reaction mixture contained 100 pmol of [14C]stearic acid,
900 pmol of unlabeled stearic acid, 2 nmol of
D-erythro-SPC, and 60 µU of the recombinant G8
enzyme in 20 µl of 25 mM sodium acetate buffer, pH 6.0, containing 0.1% Triton X-100. After incubation at 37 °C for the
periods indicated, [14C]SM was separated from
[14C]stearic acid using TLC and analyzed by BAS1500 as
described under "Experimental Procedures." E,
quantification of D by BAS1500.
|
|
Specificity and Properties of the Recombinant
SCDase--
Recombinant G8 SCDase hydrolyzed various gangliosides,
including GT1b (89.3%, value is the extent of hydrolysis of 10 nmol of
substrate after incubation with 2 mU of the enzyme at 37 °C for
16 h), GD1b (82.9%), GM3 (14.5%), neutral GSLs such as Gb4Cer (16.6%), asialoGM1 (27.0%), LacCer (28.5%), GlcCer (27.2%), GalCer (28.5%), and SM (31%). However, free ceramide was quite
resistant to hydrolysis by the enzyme (less than 5%). These results
are very consistent with the TK4 enzyme. However, clear differences in
specificity were found in the hydrolysis of C12-NBD-GalCer, in which
dodecanoic acid at the
-position was labeled with fluorescent dye
NBD, and that of 2P5N-Glc. As shown in Fig.
4A, C12-NBD-GalCer was
efficiently hydrolyzed by the G8 recombinant enzyme, whereas the
fluorescent substrate is quite resistant to hydrolysis by the TK4
enzyme. In contrast, 2P5N-Glc was only hydrolyzed by the TK4
enzyme (Fig. 4B). The metal-ion requirement of the
recombinant G8 enzyme was almost the same as that of the native enzyme
but somewhat different from that of the TK4 enzyme; EDTA at 5 mM strongly inhibited the activities of G8 enzymes but not
the TK4 enzyme, and Ca2+, Mn2+, and
Mg2+ activated the G8 enzymes at 5 mM (Fig.
4C) but not the TK4 enzyme. The optimum pH for G8 and TK4
enzymes was found to be 5.5-6.5 when the activity was determined using
[14C]GM1a as a substrate in the presence of Triton X-100
at 0.1% (Fig. 4D). The effects of Triton X-100 on both G8
and TK4 enzymes were almost the same (Fig. 4E), whereas
those of taurodeoxycholate (TDC) differed between the enzymes (Fig.
4F); the TK4 enzyme was gradually activated by increasing
the concentration of TDC up to 2%, whereas the optimum concentration
of TDC for G8 enzymes was found to be 0.5%, with a gradual decrease
beyond this. In summary, the substrate specificity and general
properties of the recombinant G8 enzyme are somewhat different from
those of the TK4 enzyme.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Comparison of the properties of the G8 with
those of TK4 enzymes. A, hydrolysis of NBD-GalCer by
SCDase. The substrate (100 pmol) was incubated with different amounts
of enzyme in 20 µl of 25 mM sodium acetate buffer, pH
6.0, containing 0.1% Triton X-100 and incubated at 37 °C for 30 min. The extent of hydrolysis of the substrate was evaluated by the
method described under "Experimental Procedures." B,
hydrolysis of 2P5N-Glc by SCDase. The substrate (100 nmol) was
incubated with different amounts of enzyme in 200 µl of 25 mM sodium acetate buffer, pH 6.0, containing 0.8% Triton
X-100 and incubated at 37 °C for 30 min. The extent of hydrolysis of
the substrate was evaluated by the method described under
"Experimental Procedures." C, effects of divalent
cations and EDTA on SCDase. The activity was assayed by the standard
method using 50 µU of SCDase and GM1a as a substrate as described
under "Experimental Procedures" except that the reaction was
performed in the presence of 5 mM metal ions or EDTA.
D, effects of pH on SCDase. The activity was measured using
50 µU of SCDase and GM1a as a substrate by the standard method except
that 300 mM GTA buffer was used instead of 25 mM sodium acetate buffer. D and E,
effects of detergents on SCDase. The activity was measured using 50 µU of SCDase and GM1a as a substrate by the standard method except
that Triton X-100 (D) or TDC (E) was used at the
indicated concentrations.
|
|
Significance of C-terminal Processing of SCDase--
The molecular
wieght of the mature SCDase was deduced to be 105,994 from the DNA
sequence of the gene encoding SCDase. This value is very consistent
with the molecular mass of recombinant SCDase expressed in E. coli (106 kDa) but quite different from that of the native SCDase
(75 kDa) purified from S. alga. This discrepancy may stem
from the post-translational processing of the enzyme in S. alga. The processing is likely to occur in the C-terminal region,
because the N-terminal sequence of the purified 75-kDa SCDase was
followed only by the putative signal sequence. Thus, we have designed
two constructs; one contains the full-length DNA encoding the 106-kDa
SCDase (pEUSCD-T) and the other contains the DNA with a C-terminal
deletion encoding the 75-kDa enzyme (pEUSCD-del). In both cases the
C-terminal end was tagged with polyhistidine (Fig.
5A). As expected, 106-kDa and
75-kDa proteins were generated by in vitro translation using
wheat germ extracts and visualized by Western blotting using anti-His
tag antibody (Fig. 5B). The activities of the 106-kDa
protein (WT) and the 75-kDa protein (DEL) were determined using
[14C]GM1a as a substrate. Both proteins hydrolyzed
[14C]GM1a to generate [14C]stearic acid
whereas wheat germ extract itself (WGE) did not (Fig. 5C).
Interestingly, the extent of hydrolysis of [14C]GM1a by
the 75-kDa protein was found to be much greater than that by the
106-kDa enzyme (Fig. 5D). This was confirmed by the experiment using different concentrations of the substrate (Fig. 5E). These results strongly suggest that C-terminal
processing is necessary for a fully active SCDase. It is noteworthy
that the 30-kDa C-terminal region is homologous to Lumbricus
terrestris lectin (Fig. 5A), although the physiological
significance of this lectin-like domain is unknown.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
SCDase activity of the deletion mutant.
A, expression vectors for in vitro translation.
Details are described under "Experimental Procedures."
B, Western blotting of the SCDase. The wild type (pEUSCD-T,
106 kDa) or deletion mutant (pEUSCD-del, 75 kDa) was subjected to
in vitro translation using Proteios wheat germ extract.
Then, an aliquot of the reaction mixture (18 µg as protein) was
subjected to 10% SDS-PAGE and transferred onto a polyvinylidene
difluoride membrane for detection with anti-His tag (C-term) monoclonal
antibody (Invitrogen). C, 10 µl (18 µg as protein) of
wheat germ extract (WGE), wheat germ extract containing the
106-kDa wild-type SCDase (WT) or wheat germ extract
containing the 75-kDa mutant SCDase (DEL) was incubated with
substrate solution (100 pmol of [14C]GM1a in 10 µl of
50 mM sodium acetate buffer, pH 6.0, containing 0.2%
Triton X-100) at 37 °C for the periods indicated.
[14C]Stearic acid was separated from
[14C]GM1 using TLC and analyzed by BAS1500 as described
under "Experimental Procedures." D, quantification of
C by BAS 1500. E, 100, 200, or 500 pmol of
[14C]GM1a (each corresponds to 5, 10, and 25 µM, respectively) was incubated with 18 µg (as protein)
of WGE, WT, or DEL at 37 °C for 6 h in 20 µl of 25 mM sodium acetate buffer, pH 6.0, containing 0.1% Triton
X-100. The extent of hydrolysis was determined by the method described
in C.
|
|
 |
DISCUSSION |
Lyso-sphingolipids are present at only low levels in normal
tissues but are abnormally accumulated in various lysosomal storage diseases. Several possible mechanisms for the formation of
lyso-sphingolipids in vivo have been proposed: 1)
sphingosine could be utilized as an acceptor substrate instead of
ceramide by UDP-galactose:ceramide:galactosyltransferase to generate
galactosylsphingosine (37), 2) acidic ceramidase catalyzes the
N-deacylation of not only ceramide but also GlcCer to
generate glucosylsphingosine (38), and 3) SCDase or a SCDase-like enzyme participates in the enzymatic N-deacylation of
various GSLs and SM. However, the molecular mechanism for
lyso-sphingolipid formation in vivo remains to be elucidated.
The first description of enzymatic N-deacylation of GSLs was
made by Hirabayashi and co-workers (16) who observed the formation of
lyso-GM2 from GM2 by Nocardia cell lysates. To date, four
microbial SCDases or SCDase-like enzymes have been reported, including
the present study. Among them, the enzymes from Pseudomonas
sp. TK4 (17) and S. alga G8 (this work) were purified to be
apparently homogenous. The G8 enzyme cloned in this study seems to be
novel judging from its molecular weight, substrate specificity, and metal-ion and detergent requirements. The molecular masses of the G8
and TK4 enzymes were estimated by SDS-PAGE to be 75 kDa (106 kDa for
recombinant enzyme expressed in E. coli) and 52 kDa, respectively, and those from other origins have not yet been
determined. Very recently, Higuchi et al. reported that the
activity of a non-microbial SCDase-like enzyme was abnormally elevated
in the skin of a patient with atopic dermatitis (11). The enzyme
hydrolyzed GlcCer as well as SM. They argued that the hydrolysis of SM
and GlcCer by the enzyme might cause the decrease of ceramide in atopic skin, because SM and GlcCer are thought to be precursors of ceramide in
epidermis (39, 40). A decrease of ceramide was actually observed in
atopic skin and seems to be related to some etiologic aspects of atopic
dermatitis, i.e. a decrease of ceramide causes a change in
epidermal permeability, facilitating invasion by allergens or irritants
(41). The purification and molecular cloning of this non-microbial
SCDase should provide further information.
The molecular cloning of a SCDase gene has been performed for the first
time in this study. The deduced amino acid sequence of G8 SCDase showed
no significant sequence similarity with other known proteins, including
other sphingolipid-degrading enzymes such as ceramidases (19, 20),
sphingomyelinases (42), and endoglycoceramidases (43-45). However, we
found a sequence homologous to the G8 SCDase in a hypothetical protein
of Streptomyces fradiae Y59 (46) and L. terrestris galactose-binding lectin (47). Streptomyces and Lumbricus proteins showed 35.9 and 25% identities at the amino acid level to the
Shewanella SCDase. Actually, Ashida et al. (18)
reported the presence of SCDase activity in a strain of
Streptomyces sp. Although TK4 SCDase has not been cloned,
its primary structure is probably different from that of G8, because probe 1 (Fig. 2), which is used for the colony hybridization of G8
SCDase, did not hybridize the genomic DNA of TK4 after digestion with
several restriction enzymes under several different conditions. It is
also worth noting that no homologous sequences for SCDase were found in
human and other mammalian DNA data bases when searched by BLAST and FASTA.
Herein we report the first isolation of a full-length DNA encoding a
lyso-sphingolipid-generating enzyme, SCDase. Identification of the DNA
encoding SCDase will make possible the isolation of novel SCDase genes
and could be useful in generating model cells/animals in which the
SCDase gene is knocked in. The availability of such information would
facilitate further development of lyso-sphingolipid biology and pathophysiology.
 |
ACKNOWLEDGEMENTS |
We thank Dr. M. Sano and H. Izu for a
generous gift of 2P5N-Glc and valuable suggestions for preparing it. We
acknowledge the encouragement of Prof. Dr. T. Nakamura of Kyushu
University during the course of this study.
 |
FOOTNOTES |
*
This work was supported by grants-in-aid for Scientific
Research of Priority Area (B) (1240204) and Research on (B) (13460044) from the Ministry of Education, Culture, Sports, Science and
Technology, Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence reported in this paper has been submitted
to the
DDBJ/GenBankTM/EBI
Data Bank with accession number AB079849.
¶
To whom correspondence should be addressed. Tel.:
81-92-642-2898; Fax: 81-92-642-2907; E-mail:
makotoi@agr.kyushu-u.ac.jp.
Published, JBC Papers in Press, February 4, 2002, DOI 10.1074/jbc.M110688200
 |
ABBREVIATIONS |
The abbreviations used are:
GSLs, glycosphingolipids;
GalCer, galactosylceramide;
GlcCer, glucosylceramide;
LacCer, lactosylceramide;
NBD, nitrobenz-2-oxa-1,3-diazole;
2P5N-Glc, 2-palmitoyl-5-nitrophenyl-
-D-glucoside;
SCDase, sphingolipid ceramide N-deacylase;
SM, sphingomyelin;
SPC, sphingosylphosphorylcholine;
HPLC, high performance liquid
chromatography;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
TDC, taurodeoxycholate;
GD1a, NeuAc
2,3Gal
1,3GalNAc
1,4(NeuAc
2,3)Gal
1,4Glc
1,1'-Cer;
GM1a, Gal
1,3GalNAc
1,4(NeuAc
2,3)Gal
1,4G1c
1,1'-Cer;
GM2, GalNAc
1,4(NeuAc
2,3)Gal
1,4G1c
1,1'-Cer;
GM3, NeuAc
2,3Gal
1,4Glc
1,1'-Cer;
Gb4Cer, GalNAc
1,3Gal
1,4Gal
1,4G1c
1,1Cer.
 |
REFERENCES |
| 1.
|
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Hakomori, S.,
Handa, K.,
Iwabuchi, K.,
Yamamura, S.,
and Prinetti, A.
(1998)
Glycobiology
8,
xi-xix[Medline]
[Order article via Infotrieve]
|
| 3.
|
Mano, N.,
Oda, Y.,
Yamada, K.,
Asakawa, N.,
and Katayama, K.
(1997)
Anal. Biochem.
244,
291-300[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Miyatake, T.,
and Suzuki, K.
(1972)
Biochem. Biophys. Res. Commun.
48,
539-543[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kobayashi, T.,
Goto, I.,
Okada, S.,
Orii, T.,
Ohno, K.,
and Nakano, T.
(1992)
J. Neurochem.
59,
1452-1458[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Neurnhofer, S.,
Conzelmann, R.,
Schwarzmann, G.,
Egge, H.,
and Sandhoff, K.
(1986)
Biol. Chem. Hoppe-Seyler.
367,
241-244[Medline]
[Order article via Infotrieve]
|
| 7.
|
Hanai, N.,
Nores, G. A.,
MacLeod, C.,
Torres-Mendez, C. R.,
and Hakomori, S.
(1988)
J. Biol. Chem.
263,
10915-10921[Abstract/Free Full Text]
|
| 8.
|
Hannun, Y. A.,
and Bell, R. M.
(1987)
Science
235,
670-674[Abstract/Free Full Text]
|
| 9.
|
Kanazawa, T.,
Nakamura, S.,
Momoi, M.,
Yamaji, T.,
Takematsu, H.,
Yano, H.,
Sabe, H.,
Yamamoto, A.,
Kawasaki, T.,
and Kozutsumi, Y.
(2000)
J. Cell Biol.
149,
943-950[Abstract/Free Full Text]
|
| 10.
|
Rodriguez-Lafrasse, C.,
and Vanier, M. T.
(1999)
Neurochem. Res.
24,
199-205[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Higuchi, K.,
Hara, J.,
Okamoto, R.,
Kawashima, M.,
and Imokawa, G.
(2000)
Biochem. J.
350,
747-756
|
| 12.
|
Sueyoshi, N.,
Maehara, T.,
and Ito, M.
(2001)
J. Lipid Res.
42,
1197-1202[Abstract/Free Full Text]
|
| 13.
|
Xu, Y.,
Zhu, K.,
Hong, G., Wu, W.,
Baudhuin, L. M.,
Xiao, Y.-J.,
and Damron, D. S.
(2000)
Nat. Cell Biol.
2,
261-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Im, D.-S.,
Heise, C. E.,
Nguyen, T.,
O'dowd, B. F.,
and Lynch, K. R.
(2001)
J. Cell Biol.
153,
429-434[Abstract/Free Full Text]
|
| 15.
|
Zhu, K.,
Baudhuin, L. M.,
Hong, G.,
Williams, F. S.,
Cristina, K. L.,
Kabarowski, J. H. S.,
Witte, O. N.,
and Xu, Y.
(2001)
J. Biol. Chem.
276,
41325-41335[Abstract/Free Full Text]
|
| 16.
|
Hirabayashi, Y.,
Kimura, M.,
Matsumoto, M.,
Yamamoto, K.,
Kadowaki, S.,
and Tochikura, T.
(1988)
J. Biochem. (Tokyo)
103,
1-4[Abstract/Free Full Text]
|
| 17.
|
Ito, M.,
Kurita, T.,
and Kita, K.
(1995)
J. Biol. Chem.
270,
24370-24374[Abstract/Free Full Text]
|
| 18.
|
Ashida, H.,
Hayashi, S.,
Sakamoto, Y.,
Tsuji, Y.,
Yamamoto, K.,
Kumagai, H.,
and Tochikura, T.
(1995)
Biosci. Biotech. Biochem.
59,
2028-2032[Medline]
[Order article via Infotrieve]
|
| 19.
|
Okino, N.,
Tani, M.,
Imayama, S.,
and Ito, M.
(1998)
J. Biol. Chem.
273,
14368-14373[Abstract/Free Full Text]
|
| 20.
|
Tani, M.,
Okino, N.,
Mitsutake, S.,
Tanigawa, T.,
Izu, H.,
and Ito, M.
(2000)
J. Biol. Chem.
275,
3462-3468[Abstract/Free Full Text]
|
| 21.
|
Kanfer, J. N.
(1969)
Methods Enzymol.
14,
660-664
|
| 22.
|
Fukano, Y.,
and Ito, M.
(1997)
Appl. Environ. Microbiol.
63,
1861-1865[Abstract]
|
| 23.
|
Buchanan, R. E., and Gibbons, N. E.
(eds)
(1974)
Bergey's Mannual of Determinative Bacteriology
, 8th Ed.
, The Williams & Wilkins Co., Baltimore, MD
|
| 24.
|
Brousius, J.,
Palmer, M. L.,
Kennedy, P. J.,
and Noller, H. F.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
4801-4805[Abstract/Free Full Text]
|
| 25.
|
Hiraishi, A.
(1992)
Lett. Appl. Microbiol.
15,
210-213[Medline]
[Order article via Infotrieve]
|
| 26.
|
Thomopson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680[Abstract/Free Full Text]
|
| 27.
|
Maidak, B. L.,
Cole, J. R.,
Parker, C. T., Jr.,
Garrity, G. M.,
Larsen, N., Li, B.,
Lilburn, T. G.,
McCaughey, M. J.,
Olsen, G. J.,
Overbeek, R.,
Pramanik, S.,
Schmidt, T. M.,
Tiedje, J. M.,
and Woese, C. R.
(1999)
Nucleic Acids Res.
27,
171-173[Abstract/Free Full Text]
|
| 28.
|
Nakagawa, T.,
Tani, M.,
Kita, K.,
and Ito, M.
(1999)
J. Biochem. (Tokyo)
126,
604-611[Abstract/Free Full Text]
|
| 29.
|
Gal, A. E.,
and Fash, F. J.
(1976)
Chem. Phys. Lipids
16,
71-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Kita, K.,
Kurita, T.,
and Ito, M.
(2001)
Eur. J. Biochem.
268,
592-602[Medline]
[Order article via Infotrieve]
|
| 31.
|
Li, Y.-T,
and Li, S.-C.
(1972)
Methods Enzymol.
28,
702-713
|
| 32.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Ohsawa, K.,
and Ebata, N.
(1983)
Anal. Biochem.
135,
409-415[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Dainese, H. P.,
Quadroni, M.,
Staudenmann, W.,
and James, P.
(1997)
Eur. J. Biochem.
264,
336-343[Medline]
[Order article via Infotrieve]
|
| 35.
|
Sambrook, H.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 36.
|
Saito, H.,
and Miura, K.
(1963)
Biochem. Biophys. Acta
72,
619-629[Medline]
[Order article via Infotrieve]
|
| 37.
|
Inui, K.,
Nishimoto, J.,
Taniike, M.,
Midorikawa, M.,
Tsukamoto, H.,
Okada, S.,
and Yabuchi, H.
(1990)
J. Neurol. Sci.
100,
124-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Yamaguchi, Y.,
Sasagasako, N.,
Goto, F.,
and Kobayashi, T.
(1994)
J. Biochem. (Tokyo)
116,
704-710[Abstract/Free Full Text]
|
| 39.
|
Holleran, W. M.,
Takagi, Y.,
Menon, G. K.,
Legler, G.,
Feingold, K., R.,
and Elias, P. M.
(1993)
J. Clin. Invest.
91,
1656-1664[Medline]
[Order article via Infotrieve]
|
| 40.
|
Uchida, Y.,
Hara, M.,
Nishio, H.,
Sidransky, E.,
Inoue, S.,
Otsuka, F.,
Suzuki, A.,
Elias, P. M.,
Holleran, W. N.,
and Hamanaka, S.
(2000)
J. Lipid Res.
41,
2071-2082[Abstract/Free Full Text]
|
| 41.
|
Bos, J. D.,
Kapsenberg, M. L.,
and Smitt, J. H.
(1994)
Lancet
343,
1338-1341[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Yamada, A.,
Tsukagoshi, N.,
Udaka, S.,
Sasaki, T.,
Makino, S.,
Nakamura, S.,
Little, C.,
Tomita, M.,
and Ikezawa, H.
(1988)
Eur. J. Biochem.
175,
213-220[Medline]
[Order article via Infotrieve]
|
| 43.
|
Izu, H.,
Izumi, Y.,
Kurome, Y.,
Sano, M.,
Kondo, A.,
Kato, I.,
and Ito, M.
(1997)
J. Biol. Chem.
272,
19846-19850[Abstract/Free Full Text]
|
| 44.
|
Sakaguchi, K.,
Okino, N.,
Izu, H.,
and Ito, M.
(1999)
Biochem. Biophys. Res. Commun.
260,
89-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Horibata, Y.,
Okino, N.,
Ichinose, S.,
Omori, A.,
and Ito, M.
(2000)
J. Biol. Chem.
275,
31297-31304[Abstract/Free Full Text]
|
| 46.
|
Ogasawara, H.,
Katashiro, Y.,
Higashi, K.,
and Urabe, H.
(1999)
Actinomycetologica
13,
82-88
|
| 47.
|
Hirabayashi, J.,
Dutta, S. K.,
and Kasai, K.
(1998)
J. Biol. Chem.
273,
14450-14460[Abstract/Free Full Text]
|
| 48.
|
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Nakagawa, A. Morotomi, M. Tani, N. Sueyoshi, H. Komori, and M. Ito
C18:3-GM1a induces apoptosis in Neuro2a cells: enzymatic remodeling of fatty acyl chains of glycosphingolipids
J. Lipid Res.,
June 1, 2005;
46(6):
1103 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|